Public preferences for corporate social responsibility activities in the pharmaceutical industry: Empirical evidence from Korea
Although corporate social responsibility (CSR) activities are common in the pharmaceutical industry, there is little empirical evidence on consumer responses to CSR practices. We investigated public awareness, preferences, and expectations regarding social contribution of the pharmaceutical industry...
Gespeichert in:
| Veröffentlicht in: | PloS one 2019-08, Vol.14 (8), p.e0221321 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 8 |
| container_start_page | e0221321 |
| container_title | PloS one |
| container_volume | 14 |
| creator | Lee, Hankil Kim, Sang Yong Kim, Goun Kang, Hye-Young |
| description | Although corporate social responsibility (CSR) activities are common in the pharmaceutical industry, there is little empirical evidence on consumer responses to CSR practices. We investigated public awareness, preferences, and expectations regarding social contribution of the pharmaceutical industry's CSR activities, and identified the factors associated with such activities. We conducted an online survey with 1,298 respondents comprising two groups: healthy individuals (546) and patients (752). Most respondents (78%) expressed interest in CSR activities undertaken by pharmaceutical companies. However, they reported a lack of awareness and experience thereof; only 26.9% were aware of and 7.9% had experience with such activities. Among our six CSR activity categories, both survey groups showed the highest preference for the "promoting public health" (healthy group: 6.34/10; patient group: 6.37/10) and "emergency disaster relief support" (6.31 and 6.35) categories. Among sub-categories, activities related to "development of innovative drugs in untreated areas" (6.63 and 6.82) and "support for research on new drug development" (6.59 and 6.84) received the highest scores. The mean expectation score of social contribution of all CSR activities was slightly higher than the mean preference score (6.37 and 6.06, respectively). The patient group exhibited a larger difference between the highest and lowest expectation scores than the healthy group (1.11 and 0.64, respectively). The results of the regression analysis revealed that being a patient, being male, and having positive attitudes toward CSR and its expected effects significantly and positively affected public preferences regarding CSR activities. We can conclude that CSR activities with high public preference might be an effective strategy to improve public awareness of the pharmaceutical industry's CSR activities. Furthermore, the highest preference for CSR activities relates to new drug development, indicating that our society believes the pharmaceutical industry's key CSR activity should be to pursue its intrinsic mission: to fulfill unmet medical needs by developing new drugs. |
| doi_str_mv | 10.1371/journal.pone.0221321 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2276833377</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A596936956</galeid><doaj_id>oai_doaj_org_article_bc1f7504ec5947259036ff102fd2926d</doaj_id><sourcerecordid>A596936956</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-d82193161164485b112e7216f587cfdb5dc577586254dd32d238f80268f03d593</originalsourceid><addsrcrecordid>eNqNk0tv1DAQxyMEoqXwDRBEQkJw2MWP2E44IFVVgRWVinhdLcePXVdJnNrOij3x1XG6abVBPSAfbI1_8x_PeCbLnkOwhJjBd1du8J1olr3r9BIgBDGCD7JjWGG0oAjghwfno-xJCFcAEFxS-jg7wrDAAGNwnP35OtSNlXnvtdFed1KH3DifS-d750XUeXDSiib3OqRIwda2sXGXCxnt1kabcNvlcaPzfiN8K6QeopWJt50aQvS79_l521t_Y9Nbq8YQufGuzb84r8XT7JERTdDPpv0k-_nx_MfZ58XF5afV2enFQtIKxYUqUUoGUghpUZSkhhBphiA1pGTSqJooSRgjJUWkUAojhXBpSoBoaQBWpMIn2cu9bt-4wKfaBY4QoyXGmLFErPaEcuKK9962wu-4E5bfGJxfc-FTbo3mtYSGEVBoSaqCIVIBTI2BABmFKkRV0vowRRvqViupu-hFMxOd33R2w9duyykDkLHxuW8mAe-uBx0ib22QumlEp90wvrskEKQfBwl99Q96f3YTtRYpAdsZl-LKUZSfkopWmFaEJmp5D5WW0q2VqdGMTfaZw9uZQ2Ki_h3XYgiBr75_-3_28tecfX3AbrRo4ia4JvVW6sE5WOxB6V0IqYnvigwBH-fkthp8nBM-zUlye3H4QXdOt4OB_wKHgQ4T</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2276833377</pqid></control><display><type>article</type><title>Public preferences for corporate social responsibility activities in the pharmaceutical industry: Empirical evidence from Korea</title><source>Public Library of Science (PLoS) Journals Open Access</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Lee, Hankil ; Kim, Sang Yong ; Kim, Goun ; Kang, Hye-Young</creator><contributor>Fredes, Eduardo Ortas</contributor><creatorcontrib>Lee, Hankil ; Kim, Sang Yong ; Kim, Goun ; Kang, Hye-Young ; Fredes, Eduardo Ortas</creatorcontrib><description>Although corporate social responsibility (CSR) activities are common in the pharmaceutical industry, there is little empirical evidence on consumer responses to CSR practices. We investigated public awareness, preferences, and expectations regarding social contribution of the pharmaceutical industry's CSR activities, and identified the factors associated with such activities. We conducted an online survey with 1,298 respondents comprising two groups: healthy individuals (546) and patients (752). Most respondents (78%) expressed interest in CSR activities undertaken by pharmaceutical companies. However, they reported a lack of awareness and experience thereof; only 26.9% were aware of and 7.9% had experience with such activities. Among our six CSR activity categories, both survey groups showed the highest preference for the "promoting public health" (healthy group: 6.34/10; patient group: 6.37/10) and "emergency disaster relief support" (6.31 and 6.35) categories. Among sub-categories, activities related to "development of innovative drugs in untreated areas" (6.63 and 6.82) and "support for research on new drug development" (6.59 and 6.84) received the highest scores. The mean expectation score of social contribution of all CSR activities was slightly higher than the mean preference score (6.37 and 6.06, respectively). The patient group exhibited a larger difference between the highest and lowest expectation scores than the healthy group (1.11 and 0.64, respectively). The results of the regression analysis revealed that being a patient, being male, and having positive attitudes toward CSR and its expected effects significantly and positively affected public preferences regarding CSR activities. We can conclude that CSR activities with high public preference might be an effective strategy to improve public awareness of the pharmaceutical industry's CSR activities. Furthermore, the highest preference for CSR activities relates to new drug development, indicating that our society believes the pharmaceutical industry's key CSR activity should be to pursue its intrinsic mission: to fulfill unmet medical needs by developing new drugs.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0221321</identifier><identifier>PMID: 31430330</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adult ; Analysis ; Animal welfare ; Business operations ; Categories ; Consumer Behavior - statistics & numerical data ; Consumer research ; Corporate social responsibility ; Disaster relief ; Drug development ; Drug Industry ; Drugs ; Empirical analysis ; Ethics ; Female ; Food ; Humans ; International organizations ; Male ; Medicine and Health Sciences ; Middle Aged ; Perceptions ; Pharmaceutical industry ; Pharmaceutical sciences ; Pharmaceuticals ; Pharmacy ; Polls & surveys ; Prescription drugs ; Public awareness ; Public health ; Regression analysis ; Republic of Korea ; Social aspects ; Social Responsibility ; Social Sciences ; Society ; Surveys and Questionnaires - statistics & numerical data ; Young Adult</subject><ispartof>PloS one, 2019-08, Vol.14 (8), p.e0221321</ispartof><rights>COPYRIGHT 2019 Public Library of Science</rights><rights>2019 Lee et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2019 Lee et al 2019 Lee et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-d82193161164485b112e7216f587cfdb5dc577586254dd32d238f80268f03d593</citedby><cites>FETCH-LOGICAL-c692t-d82193161164485b112e7216f587cfdb5dc577586254dd32d238f80268f03d593</cites><orcidid>0000-0002-7780-159X ; 0000-0003-3260-2623</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701779/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701779/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23847,27903,27904,53769,53771,79346,79347</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31430330$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Fredes, Eduardo Ortas</contributor><creatorcontrib>Lee, Hankil</creatorcontrib><creatorcontrib>Kim, Sang Yong</creatorcontrib><creatorcontrib>Kim, Goun</creatorcontrib><creatorcontrib>Kang, Hye-Young</creatorcontrib><title>Public preferences for corporate social responsibility activities in the pharmaceutical industry: Empirical evidence from Korea</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Although corporate social responsibility (CSR) activities are common in the pharmaceutical industry, there is little empirical evidence on consumer responses to CSR practices. We investigated public awareness, preferences, and expectations regarding social contribution of the pharmaceutical industry's CSR activities, and identified the factors associated with such activities. We conducted an online survey with 1,298 respondents comprising two groups: healthy individuals (546) and patients (752). Most respondents (78%) expressed interest in CSR activities undertaken by pharmaceutical companies. However, they reported a lack of awareness and experience thereof; only 26.9% were aware of and 7.9% had experience with such activities. Among our six CSR activity categories, both survey groups showed the highest preference for the "promoting public health" (healthy group: 6.34/10; patient group: 6.37/10) and "emergency disaster relief support" (6.31 and 6.35) categories. Among sub-categories, activities related to "development of innovative drugs in untreated areas" (6.63 and 6.82) and "support for research on new drug development" (6.59 and 6.84) received the highest scores. The mean expectation score of social contribution of all CSR activities was slightly higher than the mean preference score (6.37 and 6.06, respectively). The patient group exhibited a larger difference between the highest and lowest expectation scores than the healthy group (1.11 and 0.64, respectively). The results of the regression analysis revealed that being a patient, being male, and having positive attitudes toward CSR and its expected effects significantly and positively affected public preferences regarding CSR activities. We can conclude that CSR activities with high public preference might be an effective strategy to improve public awareness of the pharmaceutical industry's CSR activities. Furthermore, the highest preference for CSR activities relates to new drug development, indicating that our society believes the pharmaceutical industry's key CSR activity should be to pursue its intrinsic mission: to fulfill unmet medical needs by developing new drugs.</description><subject>Adult</subject><subject>Analysis</subject><subject>Animal welfare</subject><subject>Business operations</subject><subject>Categories</subject><subject>Consumer Behavior - statistics & numerical data</subject><subject>Consumer research</subject><subject>Corporate social responsibility</subject><subject>Disaster relief</subject><subject>Drug development</subject><subject>Drug Industry</subject><subject>Drugs</subject><subject>Empirical analysis</subject><subject>Ethics</subject><subject>Female</subject><subject>Food</subject><subject>Humans</subject><subject>International organizations</subject><subject>Male</subject><subject>Medicine and Health Sciences</subject><subject>Middle Aged</subject><subject>Perceptions</subject><subject>Pharmaceutical industry</subject><subject>Pharmaceutical sciences</subject><subject>Pharmaceuticals</subject><subject>Pharmacy</subject><subject>Polls & surveys</subject><subject>Prescription drugs</subject><subject>Public awareness</subject><subject>Public health</subject><subject>Regression analysis</subject><subject>Republic of Korea</subject><subject>Social aspects</subject><subject>Social Responsibility</subject><subject>Social Sciences</subject><subject>Society</subject><subject>Surveys and Questionnaires - statistics & numerical data</subject><subject>Young Adult</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk0tv1DAQxyMEoqXwDRBEQkJw2MWP2E44IFVVgRWVinhdLcePXVdJnNrOij3x1XG6abVBPSAfbI1_8x_PeCbLnkOwhJjBd1du8J1olr3r9BIgBDGCD7JjWGG0oAjghwfno-xJCFcAEFxS-jg7wrDAAGNwnP35OtSNlXnvtdFed1KH3DifS-d750XUeXDSiib3OqRIwda2sXGXCxnt1kabcNvlcaPzfiN8K6QeopWJt50aQvS79_l521t_Y9Nbq8YQufGuzb84r8XT7JERTdDPpv0k-_nx_MfZ58XF5afV2enFQtIKxYUqUUoGUghpUZSkhhBphiA1pGTSqJooSRgjJUWkUAojhXBpSoBoaQBWpMIn2cu9bt-4wKfaBY4QoyXGmLFErPaEcuKK9962wu-4E5bfGJxfc-FTbo3mtYSGEVBoSaqCIVIBTI2BABmFKkRV0vowRRvqViupu-hFMxOd33R2w9duyykDkLHxuW8mAe-uBx0ib22QumlEp90wvrskEKQfBwl99Q96f3YTtRYpAdsZl-LKUZSfkopWmFaEJmp5D5WW0q2VqdGMTfaZw9uZQ2Ki_h3XYgiBr75_-3_28tecfX3AbrRo4ia4JvVW6sE5WOxB6V0IqYnvigwBH-fkthp8nBM-zUlye3H4QXdOt4OB_wKHgQ4T</recordid><startdate>20190820</startdate><enddate>20190820</enddate><creator>Lee, Hankil</creator><creator>Kim, Sang Yong</creator><creator>Kim, Goun</creator><creator>Kang, Hye-Young</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-7780-159X</orcidid><orcidid>https://orcid.org/0000-0003-3260-2623</orcidid></search><sort><creationdate>20190820</creationdate><title>Public preferences for corporate social responsibility activities in the pharmaceutical industry: Empirical evidence from Korea</title><author>Lee, Hankil ; Kim, Sang Yong ; Kim, Goun ; Kang, Hye-Young</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-d82193161164485b112e7216f587cfdb5dc577586254dd32d238f80268f03d593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adult</topic><topic>Analysis</topic><topic>Animal welfare</topic><topic>Business operations</topic><topic>Categories</topic><topic>Consumer Behavior - statistics & numerical data</topic><topic>Consumer research</topic><topic>Corporate social responsibility</topic><topic>Disaster relief</topic><topic>Drug development</topic><topic>Drug Industry</topic><topic>Drugs</topic><topic>Empirical analysis</topic><topic>Ethics</topic><topic>Female</topic><topic>Food</topic><topic>Humans</topic><topic>International organizations</topic><topic>Male</topic><topic>Medicine and Health Sciences</topic><topic>Middle Aged</topic><topic>Perceptions</topic><topic>Pharmaceutical industry</topic><topic>Pharmaceutical sciences</topic><topic>Pharmaceuticals</topic><topic>Pharmacy</topic><topic>Polls & surveys</topic><topic>Prescription drugs</topic><topic>Public awareness</topic><topic>Public health</topic><topic>Regression analysis</topic><topic>Republic of Korea</topic><topic>Social aspects</topic><topic>Social Responsibility</topic><topic>Social Sciences</topic><topic>Society</topic><topic>Surveys and Questionnaires - statistics & numerical data</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Hankil</creatorcontrib><creatorcontrib>Kim, Sang Yong</creatorcontrib><creatorcontrib>Kim, Goun</creatorcontrib><creatorcontrib>Kang, Hye-Young</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Hankil</au><au>Kim, Sang Yong</au><au>Kim, Goun</au><au>Kang, Hye-Young</au><au>Fredes, Eduardo Ortas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Public preferences for corporate social responsibility activities in the pharmaceutical industry: Empirical evidence from Korea</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2019-08-20</date><risdate>2019</risdate><volume>14</volume><issue>8</issue><spage>e0221321</spage><pages>e0221321-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Although corporate social responsibility (CSR) activities are common in the pharmaceutical industry, there is little empirical evidence on consumer responses to CSR practices. We investigated public awareness, preferences, and expectations regarding social contribution of the pharmaceutical industry's CSR activities, and identified the factors associated with such activities. We conducted an online survey with 1,298 respondents comprising two groups: healthy individuals (546) and patients (752). Most respondents (78%) expressed interest in CSR activities undertaken by pharmaceutical companies. However, they reported a lack of awareness and experience thereof; only 26.9% were aware of and 7.9% had experience with such activities. Among our six CSR activity categories, both survey groups showed the highest preference for the "promoting public health" (healthy group: 6.34/10; patient group: 6.37/10) and "emergency disaster relief support" (6.31 and 6.35) categories. Among sub-categories, activities related to "development of innovative drugs in untreated areas" (6.63 and 6.82) and "support for research on new drug development" (6.59 and 6.84) received the highest scores. The mean expectation score of social contribution of all CSR activities was slightly higher than the mean preference score (6.37 and 6.06, respectively). The patient group exhibited a larger difference between the highest and lowest expectation scores than the healthy group (1.11 and 0.64, respectively). The results of the regression analysis revealed that being a patient, being male, and having positive attitudes toward CSR and its expected effects significantly and positively affected public preferences regarding CSR activities. We can conclude that CSR activities with high public preference might be an effective strategy to improve public awareness of the pharmaceutical industry's CSR activities. Furthermore, the highest preference for CSR activities relates to new drug development, indicating that our society believes the pharmaceutical industry's key CSR activity should be to pursue its intrinsic mission: to fulfill unmet medical needs by developing new drugs.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>31430330</pmid><doi>10.1371/journal.pone.0221321</doi><tpages>e0221321</tpages><orcidid>https://orcid.org/0000-0002-7780-159X</orcidid><orcidid>https://orcid.org/0000-0003-3260-2623</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1932-6203 |
| ispartof | PloS one, 2019-08, Vol.14 (8), p.e0221321 |
| issn | 1932-6203 1932-6203 |
| language | eng |
| recordid | cdi_plos_journals_2276833377 |
| source | Public Library of Science (PLoS) Journals Open Access; MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry |
| subjects | Adult Analysis Animal welfare Business operations Categories Consumer Behavior - statistics & numerical data Consumer research Corporate social responsibility Disaster relief Drug development Drug Industry Drugs Empirical analysis Ethics Female Food Humans International organizations Male Medicine and Health Sciences Middle Aged Perceptions Pharmaceutical industry Pharmaceutical sciences Pharmaceuticals Pharmacy Polls & surveys Prescription drugs Public awareness Public health Regression analysis Republic of Korea Social aspects Social Responsibility Social Sciences Society Surveys and Questionnaires - statistics & numerical data Young Adult |
| title | Public preferences for corporate social responsibility activities in the pharmaceutical industry: Empirical evidence from Korea |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T12%3A17%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Public%20preferences%20for%20corporate%20social%20responsibility%20activities%20in%20the%20pharmaceutical%20industry:%20Empirical%20evidence%20from%20Korea&rft.jtitle=PloS%20one&rft.au=Lee,%20Hankil&rft.date=2019-08-20&rft.volume=14&rft.issue=8&rft.spage=e0221321&rft.pages=e0221321-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0221321&rft_dat=%3Cgale_plos_%3EA596936956%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2276833377&rft_id=info:pmid/31430330&rft_galeid=A596936956&rft_doaj_id=oai_doaj_org_article_bc1f7504ec5947259036ff102fd2926d&rfr_iscdi=true |